Use of thyroid function tests in public clinical laboratories of Catalonia;Uso de las pruebas de función tiroidea en los laboratorios clínicos de la red sanitaria pública de Cataluña

Quimica Clinica

Volumn 21, Issue 4, 2002, Pages 254-261

  Rodríguez Espinosa, José ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; CLINICAL LABORATORY; COST; HORMONE DETERMINATION; PRACTICE GUIDELINE; PUBLIC HEALTH; SPAIN; THYROID FUNCTION TEST;

EID: 0036032551     PISSN: 11392436     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Feldkamp CS, Carey JL. An algorithmic approach to thyroid function testing in a managed care setting. Am J Clin Pathol 1996; 105: 11-16
2. O'Reilly DStJ. Thyroid function test - A time for a reassessment. BMJ 2000; 320: 1332-1334.
3. Roti E, Gardini E, Magotti MG, Pilla S, Minelli R, Salvi M, et al. Are thyroid function tests too frequently and inappropriately requested? J Endocrinol Invest 1999; 22: 184-190.
4. Nolan JP, Tarsa NJ, DiBenedetto G. Case-finding for unsuspected thyroid disease: Costs and health benefits. Am J Clin Pathol 1985; 83: 346-355.
5. Vidal-Trécan G, Toubert M-E, Paycha F, Fulla Y, Fior R, Abella A, et al. Les dosages hormonaux thyroïdiens à l'assistance Publique-Hôpitaux de Paris: Prescriptions, coût et opinions des médecins qualifiés en endocrinologie. Ann d'Endocrinol (Paris) 1999; 60: 48-55.
6. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of laboratory test in thyroid disorders. JAMA 1990; 263: 1529-1532.
7. Bayer M. Recent developments and most effeective laboratory tests for assessment of thyroid status. Med Clin North Am 1991; 75: 1-25.
8. Rodríguez Espinosa J, Montañés Bermúdez R, Ordóñez Llanos J, Cortés Rius M, González Sastre F. Evaluación de una nueva estrategia para la detección de disfunción tiroidea. Med Clín (Barc) 1990; 94: 406-413.
9. de los Santos ET, Starich GH, Mazzaferri EL. Sensitivity, specificity, and cost-effectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med 1989; 149: 526-532.
10. Schectman JM, Pawlson GL. The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care setting. J Gen Intern Med 1990; 5: 9-15.
11. Hamburger JI, Kaplan MM. Diagnosis of thyroid dysfunction in ambulatory patients: Primacy of the supersensitive thyroid-stimulating hormone assay. Compr Ther 1990; 16: 3-7.
12. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: A decision and cost-effectiveness analysis. JAMA 1996; 276: 285-292.
13. Davey RX, Clarke MI, Webster AR. Thyroid function testing based on assay of thyroid stimulating hormone: Assessing an algorithm's reliability. Med Aust 1996; 164: 329-332.
14. Nordyke RA, Reppun TS, Madanay LD, Woods JC, Goldstein AP, Miyamoto LA. Alternative sequences to thyrotropin and free thyroxine assays for routine thyroid function testing. Arch Intern Med 1998; 158: 266-272.
15. Ladenson PW, Singer PA, Ain KB, Bagchi N, Bigos ST, Levy EG, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-1575.
16. Helfand M, Redfern CC. Screening for thyroid disease: An update. Ann Intern Med 1998; 129; 144-158.
17. American College of Physicians. Screening for thyroid disease. Ann Intern Med 1998; 129: 141-143.
18. Riesco Prieto M, Barcelo Bennassar A, Pérez Esteban G, Ribes Valles JL. Evaluación de un protocolo diagnóstico de disfunción tiroidea. Aten Primaria 1997; 31: 355-360.
19. Wartofsky L. The scope and impact of thyroid disease. Clin Chem 1996; 42: 121-124.
20. Klee GG, Hay ID. Biochemical thyroid function testing. Mayo Clin Proc 1994; 69: 469-470.
21. Larsson A, Palmer M, Hultén G, Tryding N. Large differences in laboratory utilisation between hospitals in Sweden. Clin Chem Lab Med 2000; 38: 383-389.
22. Sisson JC, Schoomaker EB, Ross JC. Clinical decision analysis. The hazard of using additional data. JAMA 1976; 236: 1259-63.
23. Klee GG. Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements. Clin Chem 1996; 42: 155-159.
24. Després N, Grant A. Antibody interference in thyroid assays: A potential for clinical misinformation. Clin Chem 1998; 44: 440-454.
25. Klee GG, Hay D. Biochemical testing of thyrod function. Endocrinol Metab Clin N Am 1997; 26: 763-775.
26. DeGroot LJ, Mayor G. Admission screening by thyroid function tests in an acute general care teaching hospital. Am J Med 1992; 93: 558-564.
27. Ross DS, Danies GH, Gouveia D. The use and limitations of a chemiluminiscent thyrotropin assay as a single thyroid function test in an outpatient endocrine clinic. J Clin Endocrinol Metab 1990; 71: 764-769.
28. Spencer CA, Eigen A, Shen D, et al. Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 1987; 33: 1391-1396.
29. Bauer DC, Brown AN. Sensitive thyrotropin and free thyroxine testing in out-patients. Are both necessary? Arch Intern Med 1996; 156: 2333-2337.
30. Davey RX, Clarke MI, Webster AR. Thyroid function testing based on assay of thyroid-stimulating hormone: Assessing an algorithm's reliability. MJA 1996; 164: 329-332.
31. Vanderpump MPJ, Ahlquist JAO, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. BMJ 1996; 313: 539-544.
32. Weetman AP. Hypothyroidism: Screening and subclinical disease. BMJ 1997; 314: 1175-1178.
33. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, et al. Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998; 83: 1121-1127.
34. Ayala C, Cózar MV, Rodríguez JR, Silva H, Pereira JL, García-Luna PP. Enfermedad tiroidea subclínica en la población anciana institucionalizada. Med Clín (Barc) 2001; 117: 534-535.
35. Altshuler CH. Data utilization, not data acquisition, is the main problem. Clin Chem 1994; 40: 1616-1620.
36. Comisión de Hormonas de la Sociedad Española de Bioquímica Clínica y Patología Molecular. El laboratorio de hormonología y la automatización del inmunoanálisis. Endocrinología 1995; 42: 233-235.
37. Erickson K. Optomal use of the laboratory in the changing healthcare environment: Do lab tests cost money or save money? Clin Chem 1994; 40: 1615.
38. Kricka LJ. Interferences in immunoassayæsfill a threat. Editorial. Clin Chem 2000; 46: 1037-1038.
39. Waise A, Plebani M. Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? Ann Clin Biochem 2001; 38: 589-595.